SHERMIN RUTHERFORD: Open Payments
NPI 1942646393 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,905 in 69 payments from 17 companies in 2025. Trend: 2023 $1,627 · 2024 $1,556 · 2025 $1,905
Food & beverage: $1,905
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $390 |
| ABBVIE INC. | 13 | $279 |
| Dendreon Pharmaceuticals LLC | 7 | $242 |
| PFIZER INC. | 11 | $225 |
| Procept Biorobotics Corporation | 1 | $118 |
| Sumitomo Pharma America, Inc. | 5 | $112 |
| AstraZeneca Pharmaceuticals LP | 5 | $106 |
| Astellas Pharma US Inc | 4 | $96 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $61 |
Products named: XTANDI, ERLEADA, PROVENGE, BOTOX, LYNPARZA, RYBREVANT, AQUABEAM ROBOTIC SYSTEM, GEMTESA.
Industry payments across CA — which companies pay providers there.
